Sean Nolan
Board Member
Taysha Gene Therapies, Inc. (TSHA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sean Nolan
Sean Nolan is recorded as CEO and Board Member at Taysha Gene Therapies, Inc. (TSHA). Taysha Gene Therapies, Inc. reported in an 8-K filed December 22, 2022 that Sean Nolan was appointed Chief Executive Officer, effective December 16, 2022. The proxy statement of Taysha Gene Therapies, Inc. reports total compensation of $4,099,065 for Sean Nolan in fiscal 2025, including a base salary of $645,840. Disclosed compensation is on record for 4 fiscal years. Sean Nolan has spoken on 14 earnings calls and 1 other investor event across 1 company, most recently for Taysha Gene Therapies, Inc. on August 11, 2026.
“On December 16, 2022, the Board appointed Sean Nolan as the Company's Chief Executive Officer, effective as of the effective time of Mr. Session's resignation.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Taysha Gene Therapies, Inc.
Other people whose current roles at this company are on record from its filings.
- Kamran Alam CFO
- Laura Sepp-Lorenzino Board Member
- Sean Stalfort Board Member
- Sukumar Nagendran Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Taysha Gene Therapies, Inc. (TSHA) | Chief Executive Officer and Director | $645,840 | $4,099,065 |
| 2024 | Taysha Gene Therapies, Inc. (TSHA) | Chief Executive Officer and Director | $621,000 | $4,727,861 |
| 2023 | Taysha Gene Therapies, Inc. (TSHA) | Chief Executive Officer and Director | $600,000 | $1,522,515 |
| 2022 | Taysha Gene Therapies, Inc. (TSHA) | Chief Executive Officer and Director | $25,000 | $1,899,276 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.